Sumitomo Mitsui Trust Holdings, Inc. Care Dx, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,576,261 shares of CDNA stock, worth $76.3 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,576,261
Previous 2,748,338
6.26%
Holding current value
$76.3 Million
Previous $29.1 Million
37.47%
% of portfolio
0.03%
Previous 0.02%
Shares
21 transactions
Others Institutions Holding CDNA
# of Institutions
157Shares Held
53.5MCall Options Held
60.8KPut Options Held
34.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.7MShares$169 Million0.81% of portfolio
-
Black Rock Inc. New York, NY5.29MShares$157 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$130 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.91MShares$116 Million1.02% of portfolio
-
Nikko Asset Management Americas, Inc.2.58MShares$76.3 Million0.47% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.58B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...